Reports for SANOFI-AVENTIS CANADA INC
Company Name
SANOFI-AVENTIS CANADA INC
Totals |
||
Shortage reports |
289 |
|
Actual shortage: | 4 (1%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 16 (6%) | |
Resolved: | 269 (93%) | |
Discontinuation Reports |
58 |
|
To be discontinued: | 7 (12%) | |
Discontinued: | 51 (88%) | |
Reversed: | 0 (0%) | |
Late reports |
21 (6%) |
|
Overdue reports |
6 (55%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
GLUCOPHAGE | 500MG | TABLET | Resolved | 2023-02-14 | 2023-06-23 | 184615 |
GLUCOPHAGE | 500MG | TABLET | Resolved | 2023-02-14 | 2023-06-23 | 184642 |
GLUCOPHAGE | 500MG | TABLET | Resolved | 2023-07-19 | 2023-09-01 | 199227 |
GLUCOPHAGE | 850MG | TABLET | Resolved | 2019-02-20 | 2019-07-19 | 76402 |
GLUCOPHAGE | 850MG | TABLET | Resolved | 2022-01-21 | 2022-03-30 | 153372 |
GLUCOPHAGE | 850MG | TABLET | Resolved | 2022-12-14 | 2023-09-01 | 178385 |
IMOVANE | 5.0MG | TABLET | Resolved | 2018-04-10 | 2019-03-08 | 45394 |
IMOVANE | 7.5MG | TABLET | Resolved | 2018-12-06 | 2019-02-15 | 68864 |
JEVTANA | 40MG | SOLUTION | Avoided shortage | 2019-06-27 | 2019-07-19 | 87765 |
KAYEXALATE | 100% | POWDER | Resolved | 2019-01-15 | 2019-02-06 | 72245 |
KAYEXALATE | 100% | POWDER | Resolved | 2019-04-23 | 2019-05-24 | 82271 |
KAYEXALATE | 1G | POWDER FOR SUSPENSION POWDER | Resolved | 2024-07-26 | 2024-08-01 | 233798 |
KEVZARA | 200MG | SOLUTION | Resolved | 2020-02-21 | 2022-07-20 | 106826 |
KEVZARA | 150MG | SOLUTION | Resolved | 2023-04-12 | 2023-08-16 | 189382 |
KEVZARA | 150MG | SOLUTION | Resolved | 2023-01-18 | 2023-03-15 | 181429 |
KEVZARA | 150MG | SOLUTION | Resolved | 2022-04-22 | 2022-08-26 | 159316 |
KEVZARA | 200MG | SOLUTION | Resolved | 2023-03-31 | 2023-04-04 | 188465 |
KEVZARA | 200MG | SOLUTION | Resolved | 2022-11-08 | 2022-12-04 | 173986 |
KEVZARA | 200MG | SOLUTION | Resolved | 2022-03-01 | 2022-05-31 | 155759 |
KEVZARA | 200MG | SOLUTION | Resolved | 2022-11-17 | 2023-02-11 | 175209 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
RENVELA | 2.4G | POWDER FOR SUSPENSION | Discontinued | 2024-10-04 | 2025-04-03 | 239436 |
RENVELA | 0.8G | POWDER FOR SUSPENSION | Discontinued | 2024-10-04 | 2025-04-03 | 239433 |
RENVELA | 800MG | TABLET | To be discontinued | 2025-03-31 | 2025-03-31 | 253680 |
RIFADIN | 300MG | CAPSULE | Discontinued | 2021-02-16 | 2021-02-16 | 134218 |
RIFADIN | 150MG | CAPSULE | Discontinued | 2021-02-16 | 2021-02-16 | 134215 |
RIFATER | 300MG 120MG 50MG | TABLET | Discontinued | 2017-03-20 | 2017-03-20 | 3688 |
SECTRAL | 200MG | TABLET | Discontinued | 2018-07-09 | 2018-09-07 | 54767 |
SECTRAL | 400MG | TABLET | Discontinued | 2017-03-20 | 2017-03-20 | 3692 |
SECTRAL | 100MG | TABLET | Discontinued | 2018-09-17 | 2018-10-03 | 61609 |
TALWIN | 50MG | TABLET | Discontinued | 2020-11-09 | 2021-02-06 | 128146 |
TALWIN | 50MG | TABLET | Discontinued | 2021-02-09 | 2021-02-09 | 133620 |
TAXOTERE | 80MG | SOLUTION | To be discontinued | 2018-06-27 | 2018-10-17 | 53064 |
TAXOTERE | 20MG | SOLUTION | Discontinued | 2018-02-23 | 2018-05-28 | 40870 |
TUSSIONEX | 5MG 10MG | SUSPENSION | Discontinued | 2019-11-11 | 2020-03-24 | 98368 |
TUSSIONEX | 5MG 10MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2017-08-17 | 2017-08-22 | 19700 |
ZALTRAP | 200MG | SOLUTION | Discontinued | 2020-07-30 | 2020-07-30 | 121390 |
ZALTRAP | 100MG | SOLUTION | Discontinued | 2020-07-30 | 2020-07-30 | 121387 |
ZUACTA | 0.075% | CREAM | Discontinued | 2020-07-30 | 2020-07-30 | 121381 |